The effective implementation and integration of technological advancements in cell and gene therapy manufacturing can be significantly impacted by the development of long-term strategic collaborations, to support technology transfer and process integration. This panel will explore emerging technologies and key factors that have critically contributed to successful establishment of a robust clinical manufacturing process. Panelists will also examine the current state of cell therapy processing, gaps to be addressed, advancements in manufacturing automation, and discuss considerations for future design strategies using emerging AI/ML tools.
Chair:
Betty Woo, Ph.D., Vice President, Cell, Gene and Advanced Therapies, Thermo Fisher Scientific
Speakers:
Ivie Aifuwa, Ph.D., Director, Development Engineering and Automation, Bristol Myers Squibb
Seth Ettenberg, Ph.D., President and CEO, BlueRock Therapeutics
Dan Herring, General Manager, Advanced Therapies, Patheon
